Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Frontiers in Cancer Immunotherapy 2022

Frontiers in Cancer Immunotherapy 2022

Monday, May 9, 2022, 9:00 AM - Wednesday, May 11, 2022, 5:00 PM EDT

New York City

Presented By

Cancer Discussion Group

The New York Academy of Sciences

 

Immunotherapy has fundamentally shifted the paradigm for cancer treatment, delivering effective and durable responses for numerous patients. Nonetheless, challenges remain in understanding why some tumor types are refractive to immunotherapy and how to better predict patient responses to treatment.  This conference—featuring keynote lectures by Dr. Abul K. Abbas and Dr. Gary Nolan—represents the Academy’s 9th annual convening of immuno-oncology experts across academia and industry to share cutting-edge discoveries. Topics will include

  • examining whole tumors,
  • intertumoral therapies,
  • targeting tumor resistance,
  • therapeutic potential of cytokines,
  • combination therapy, and
  • computational bioinformatics.

Call for Abstracts

Abstract submissions are invited for poster or short talk presentations. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Friday, February 25, 2022.

Scientific Organizing Committee

Christopher Boshoff, MD, PhD

Pfizer Inc

Renier Brentjens, MD, PhD

Roswell Park Comprehensive Cancer Center

Padmanee Sharma, MD, PhD

MD Anderson Cancer Center

George Zavoico, PhD

Cue Biopharma

Sonya Dougal, PhD

The New York Academy of Sciences

Barbara Knappmeyer, PhD

The New York Academy of Sciences

Keynote Speakers

Abul K. Abbas, PhD

University of California, San Francisco

Garry P. Nolan, PhD

Stanford University

Speaker

Elana Judith Fertig, PhD

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

Miriam Merad, MD, PhD

Icahn School of Medicine at Mount Sinai

Vinay K. Puduvalli, MD

MD Anderson Cancer Center

David Reardon, MD

Dana Farber Cancer Institute

Robert C. Rickert, PhD

Pfizer Inc

Naveen Sharma, PhD

MD Anderson Cancer Center